BMI 30.0 kg m 2 or 27.0 kg m 2 with the presence of at least one of the following weight-related comorbidities (treated or untreated): hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease
Description Product Information Product Name: Retatrutide (LY3437943), 99.70% purity peptide (TFA removed) Description: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G) , the EC50 values are 5.79 nM, 0.0643 nM, and 0.775 nM respectively [1]
The article names severe upper abdominal pain radiating to the back as a sign of possible acute pancreatitis, along with persistent severe vomiting, vision changes, and signs of hypoglycemia in insulin-treated patients
Hims is a fully digital telehealth platform that allows patients to fill out detailed online questionnaires about their health, lifestyle, and symptoms